Pharmaceuticals, Biotechnology and Life Sciences
Akebia has substantial revenue growth opportunity for Auryxia following robust2018 ommercial performance, while the first regulatory submission for vadadustat expected in 2019 inJapan, following positive top-line results from pivotal phase 3 studiesin Japanese subjects with anemia due to chronic kidney disease
IRVINE, Calif. & BASEL, Switzerland–(BUSINESS WIRE)–Urovant Sciences (Nasdaq: UROV), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies…
Oral Plenary Presentation Receives SGO Presidential Award LOS ANGELES–(BUSINESS WIRE)–Puma Biotechnology, Inc. (Nasdaq: PBYI), a biopharmaceutical company, announced today that…
RICHMOND, Va.–(BUSINESS WIRE)—-Virginia Bio, the statewide non-profit trade association for the life science industry, announced today that after seven years…
HOUSTON–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/celltherapy?src=hash" target="_blank"gt;#celltherapylt;/agt;–SpinalCyte, LLC, a Texas-based regenerative medicine company focused on regrowth of the spinal disc using Human Dermal…
STRASBOURG, France–(BUSINESS WIRE)– Transgene (Euronext Paris: TNG) (Paris:TNG), a biotech company that designs and develops virus-based immunotherapies against cancers and…
Danimer looks to expand existing HQ and bring new jobs to rural Georgia, underscoring the economic and community development impact…
NEW YORK–(BUSINESS WIRE)–TransPerfect Life Sciences, a leading provider of technologies and services to support clinical trials and product development for…
Life Sciences Industry Leader Andrew Setikas to Take the Helm of CLSA’s Business Development, Membership and Strategic Alliance Activities SAN…
Proceeds Will Fund Start-Up Activities for Current and Future Clinical Trials HIGH POINT, N.C.–(BUSINESS WIRE)–vTv Therapeutics Inc. (Nasdaq:VTVT) (the “Company”)…